Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder

Norman R. Zinner, John P. Tuttle, Leonard S. Marks

World Journal of Urology · 2005 · 97 citations · 15 references

Concepts

References

15